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Renal size and cardiovascular risk in 
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Gemma Carreras-Badosa1, Francis de Zegher6, Lourdes Ibáñez7,8, Judit Bassols2 &  
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Renal size is an important parameter for the evaluation and diagnosis of kidney disease and has been 
associated with several cardiovascular risk factors in patients with kidney failure. these results are 
however discordant and studies in healthy children are lacking. We aimed to study the association 
between renal size (length and volume) and cardiovascular risk parameters in healthy children. 
Clinical, analytical and ultrasound parameters [renal length, renal volume, perirenal fat and carotid 
intima-media thickness (cIMT)] were determined in 515 healthy prepubertal children (176 lean, 
208 overweight and 131 obese). Renal length and volume associated significantly and positively 
with several anthropometric and cardiovascular risk parameters including cIMt and systolic blood 
pressure (sBp) (all p < 0.001). Renal length and volume associated with cIMT and SBP in all study 
subgroups, but these associations were predominant in obese children, in whom these associations 
were independent after adjusting for age, gender and BsA (all p < 0.05). In multivariate analyses in the 
study subjects as a whole, renal length was an independent predictor of cIMt (β = 0.310, p < 0.0001) 
and sBp (β = 0.116, p = 0.03). Renal size associates with cIMT and SBP, independent of other well-
established cardiovascular risk factors, and may represent helpful parameters for the early assessment 
of cardiovascular risk in children.
The kidney plays a central role in the regulation of electrolyte homeostasis and blood pressure and its dysregula-
tion has been associated with several cardiovascular diseases (CVD)1–3.
Arterial vascular disease, characterized by increased systolic blood pressure and atherosclerosis, are the pri-
mary types of CVD present in patients with kidney failure4. Atherosclerosis is an intimal disease produced by 
the presence of plaques that cause occlusive lesions5. A surrogate marker of atherosclerosis is the intima-media 
thickness of the carotid wall (cIMT)6. cIMT is easily detectable by ultrasound and is also regarded as an indicator 
of preclinical atherosclerosis in children7.
In fact, renal size may be a marker for the loss of kidney mass and function8,9, as several authors have described 
associations between renal volume, nephron mass and kidney disease10–12. Besides renal volume, renal length has 
also been associated with nephron mass and renal function (estimated by GFR)13–15. In children, the studies are 
scarce but indicate that renal size positively correlates with its functionality16.
Several studies have examined the relationship between blood pressure and kidney measurements in different 
groups of patients17–20; however, there is a great discrepancy in the results derived from these studies and no inves-
tigations have been performed in healthy children. cIMT has been associated with renal function in adults21–24 
and perirenal fat in children25; however, studies about the association between cIMT and renal size are lacking.
Given that there is an accumulating body of evidence suggesting an association between kidney measurements 
and CVD, and that cardiovascular risk factors may be present in early life, we aimed to study the association 
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between renal size (length and volume) and cardiovascular risk parameters (cIMT and SBP) in children in order 
to identify novel markers that can be easily assessed and used in the early prevention of CVD.
Results
Clinical, laboratory and ultrasonography assessments are shown in the studied subjects as a whole and in sub-
groups thereof according to BMI (lean, overweight and obese) (Table 1). Renal parameters (length, volume and 
perirenal fat) were higher in overweight and obese, compared to lean children (all p < 0.0001) and in obese, com-
pared to overweight children (all p < 0.0001).
In all the studied subjects, renal length and renal volume associated significantly and positively with several 
anthropometric and cardiovascular risk parameters including weight-SDS, height-SDS, BMI-SDS, BSA, waist, fat 
mass, SBP, DBP, insulin, HOMA-IR, TG, creatinine and cIMT and negatively with HDL-cholesterol (all p < 0.001) 
(Table 2).
The associations of renal length and renal volume with cIMT and SBP were significant in all BMI subgroups 
(all between p < 0.05 and p < 0.0001), although they were predominant (higher correlation coefficients) in obese 
children (Fig. 1 and Table 3). A number of these associations were maintained after adjusting for age, gender and 
BSA (Table 4). Renal length associated with cIMT in all studied subgroups and with SBP in obese children, while 
renal volume associate with cIMT and SBP in obese children (all p < 0.05). We also evaluated the interaction 
effect of obesity in theses associations and the results showed a significant interaction of obesity in the association 
between renal length and SBP (p = 0.03).
We were also interested to know if both renal length and perirenal fat were able to independently predict these 
cardiovascular risk parameters. To this aim, we performed additional multiple regression analyses of cIMT and 




<1) (n = 176)
Overweight (1< BMI-
SDS <2) (n = 208)
Obese (BMI-SDS 
>2) (n = 131)
Clinical assessments
Age (year) 8.7 ± 0.1 8.1 ± 0.2 8.9 ± 0.1** 9.3 ± 0.2**
Gender (%F) 45.0 46.0 45.7 42.7
Birth weight (kg) 3.1 ± 0.1 2.9 ± 0.1 3.1 ± 0.1* 3.3 ± 0.1**
Birth weight-SDS 0.09 ± 0.07 −0.41 ± 0.1 0.27 ± 0.1** 0.54 ± 0.2**
Weight (kg) 39.7 ± 0.7 26.0 ± 0.6 41.8 ± 0.8** 54.9 ± 1.3**ππ
Weight-SDS 0.95 ± 0.07 −0.62 ± 0.05 1.16 ± 0.05** 2.74 ± 0.08**ππ
Height (cm) 135.6 ± 0.6 128.3 ± 1.1 137.7 ± 0.9** 142.1 ± 1.1**ππ
Height-SDS 0.53 ± 0.05 −0.03 ± 0.09 0.68 ± 0.08** 1.05 ± 0.1**π
BMI (kg/m2) 20.75 ± 0.21 15.4 ± 0.1 21.5 ± 0.2** 26.7 ± 0.3**ππ
BMI-SDS 0.85 ± 0.06 −0.8 ± 0.03 1.1 ± 0.04** 2.7 ± 0.06**ππ
BSA (m2) 1.2 ± 0.01 0.9 ± 0.01 1.3 ± 0.02** 1.5 ± 0.02**ππ
Fat mass (Kg) 9.8 ± 0.4 4.7 ± 0.3 10.9 ± 0.6** 14.9 ± 1.1**π
Waist (cm) 68.2 ± 0.7 54.4 ± 0.4 71.2 ± 0.7** 82.2 ± 1.2**ππ
SPB (mmHg) 108.5 ± 0.5 103.7 ± 0.6 109.7 ± 0.7** 113.1 ± 0.9**ππ
DBP (mmHg) 62.4 ± 0.4 60.1 ± 0.5 61.9 ± 0.5* 66.5 ± 0.8**ππ
Laboratory assessments
Insulin (mIU/L) 6.9 ± 0.3 3.2 ± 0.2 6.9 ± 0.4** 11.5 ± 0.7**ππ
HOMA-IR 1.5 ± 0.1 0.7 ± 0.05 1.5 ± 0.08** 2.5 ± 0.2**ππ
Triacylglycerol (mg/dL) 66.2 ± 1.6 48.9 ± 1.4 68.4 ± 2.6** 85.2 ± 3.7**ππ
HDL-cholesterol (mg/dL) 42.5 ± 0.3 40.7 ± 0.6 43.3 ± 0.5* 43.7 ± 0.6*
Urea (mg/dL) 30 ± 0.3 30.9 ± 0.5 29.7 ± 0.5 29.4 ± 0.6*
eGFR (mL/min per 1.73 m2) 150.2 ± 1 148.7 ± 1.7 149.7 ± 1.6 152.9 ± 2.1
ALT (U/L) 19.4 ± 0.4 16.1 ± 0.3 19.2 ± 0.5* 24.3 ± 1.1**ππ
GGT (U/L) 13.8 ± 0.2 11.5 ± 0.2 13.8 ± 0.3** 16.9 ± 0.5**ππ
Ultrasonography assessments
Renal length (cm) 8.9 ± 0.05 8.2 ± 0.07 9.0 ± 0.06** 9.5 ± 0.09**ππ
Renal volume (cm3) 81.2 ± 1.2 67.2 ± 1.5 83.1 ± 1.7** 97.2 ± 2.5**ππ
Perirenal fat (cm) 0.20 ± 0.002 0.18 ± 0.004 0.20 ± 0.004* 0.23 ± 0.005**ππ
cMT (cm) 0.040 ± 0.000 0.038 ± 0.000 0.040 ± 0.000* 0.043 ± 0.000**ππ
Table 1. Clinical, laboratory and ultrasonography assessments in the studied subjects as a whole and in 
subgroups thereof according to BMI (lean, overweight and obese). Data are shown as mean ± SEM. BMI, 
body mass index; SDS, standard deviation score; BSA, body surface area; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; eGFR, estimated glomerular filtration rate; ALT: alanine-aminotransferase; GGT: 
gamma-glutamyl transferase; cIMT, carotid intima-media thickness. **p < 0.0001 vs Lean, *p < 0.05 vs Lean, 
ππp < 0.0001 vs Overweight, πp < 0.05 vs Overweight.
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length and perirenal fat as independent variables, together with age, gender, BSA, and serum lipids. The regres-
sion model of cIMT showed that renal length (β = 0.310, p < 0.0001) and perirenal fat (β = 0.233, p < 0.0001) 
were independent predictors of cIMT and explained 21.1% of the variance in cIMT. The regression model of SBP 
showed that renal length (β = 0.116, p = 0.03) and BSA (β = 0.463, p < 0.0001) were independent predictors of 
SBP and explained 30.7% of the variance in SBP (Table 5).
Discussion
Our study showed that renal size associated with cIMT and SBP, independently of other well-established risk 
factors such as age, gender, BSA and serum lipids in healthy prepubertal children.
The size of the kidney varies and is mainly affected by age, gender, height and BMI26. Kidney size provides 
a rough indication of renal function and seems to be related to a number of risk factors for cardiovascular dis-
ease; however, the studies reporting relationships between renal size and blood pressure have shown contro-
versial findings. For instance, renal volume adjusted for sex, age and BSA was inversely correlated with SBP in 
a study of Australian aboriginal children and adults (n = 668)19. These results could be attributable to the rather 
low birth weight of the studied subjects, a common characteristic (up to 60%) among aboriginal people. It is 
known that low nephron numbers and higher blood pressure could be caused by fetal adaptation to intrauterine 
growth-restriction27. However, Gurusinghe et al.18 showed that total kidney volume was positively associated 
with SBP indices in children below 21 years (n = 84) diagnosed with primary hypertension, contrary to which 
they were expecting since hypertensive patients are found to have fewer glomeruli than their normotensive coun-
terparts28. They claimed that low birth weight may have a greater impact on BP with increasing age29. Yet, other 
studies disclosed that there is no significant correlation between blood pressure and renal size in healthy adults 
(n = 185), after correcting for age, sex and BMI30. Similarly, renal volume was related to renal function but not 
with blood pressure in a population-based cohort study of children (n = 6397)31. In a study of hypertensive and 
control adult patients (n = 195)32, the authors found a correlation between BMI, birth weight, renal volume and 
blood pressure only in the hypertensive group.
Renal length Renal volume
r P r P
Clinical assessments
Age (year) 0.619 <0.0001 0.641 <0.0001
Birth Weight-SDS 0.235 <0.0001 0.216 <0.0001
Birth Height-SDS 0.262 <0.0001 0.229 <0.0001
Weight-SDS 0.520 <0.0001 0.503 <0.0001
Height-SDS 0.370 <0.0001 0.337 <0.0001
BMI-SDS 0.483 <0.0001 0.470 <0.0001
BSA (m2) 0.740 <0.0001 0.762 <0.0001
Waist (cm) 0.615 <0.0001 0.604 <0.0001
Fat Mass (Kg) 0.426 <0.0001 0.471 <0.0001
SPB (mmHg) 0.458 <0.0001 0.450 <0.0001
DBP (mmHg) 0.217 <0.0001 0.213 <0.0001
Laboratory assessments
Insulin (mIU/L) 0.410 <0.0001 0.451 <0.0001
HOMA-IR 0.409 <0.0001 0.447 <0.0001
Triacylglycerol (mg/dL) 0.233 <0.0001 0.243 <0.0001
HDL-cholesterol (mg/dL) −0.297 <0.0001 −0.263 <0.0001
Creatinine (μmol/L) 0.314 <0.0001 0.309 <0.0001
Urea (mg/dL) −0.088 0.04 −0.051 Ns
eGFR (mL/min) 0.123 0.005 0.123 0.005
ALT (U/L) 0.285 <0.0001 0.321 <0.0001
GGT (U/L) 0.361 <0.0001 0.390 <0.0001
Ultrasonography assessments
Renal length (cm) — — 0.758 <0.0001
Renal volume (cm3) 0.758 <0.0001 — —
Perirenal fat (cm) 0.422 <0.0001 0.397 <0.0001
cIMT (cm) 0.408 <0.0001 0.311 <0.0001
Table 2. Correlation coefficients for renal length and renal volume with clinical, laboratory and 
ultrasonography assessments in the study subjects. p and r values are from Pearson correlation analyses. BMI, 
body mass index; SDS, standard deviation score; BSA, body surface area; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; eGFR, estimated glomerular filtration rate; ALT: alanine-aminotransferase; GGT: 
gamma-glutamyl transferase; cIMT, carotid intima-media thickness.
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Figure 1. Correlations between renal length and renal volume with cIMT and SBP according to BMI 
categories. White dots and dotted lines indicate lean children (BMI-SDS < 0), grey dots and dashed line indicate 




Lean (BMI-SDS <1) 
(n = 176)
Overweight  
(1< BMI-SDS <2) 
(n = 208)
Obese (BMI-SDS >2) 
(n = 131)
cIMT r p r p r p r p
Renal length 0.408 <0.0001 0.336 <0.0001 0.353 0.001 0.291 0.001
Renal volume 0.311 <0.0001 0.152 0.04 0.214 0.002 0.268 0.002
SBP r p r p r p r p
Renal length 0.458 <0.0001 0.293 <0.0001 0.287 <0.0001 0.468 <0.0001
Renal volume 0.450 <0.0001 0.301 <0.0001 0.274 <0.0001 0.459 <0.0001
Table 3. Correlation coefficients for cardiovascular risk factors (cIMT and SBP) with renal parameters in 
the study subjects as a whole and in subgroups thereof according to BMI (lean, overweight and obese). p and 
r values are from Pearson correlation analyses. cIMT: carotid intima-media thickness, SBP: systolic blood 
pressure.
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Our findings in healthy prepubertal children showed that renal length and volume associate with SBP mainly 
in obese children. In fact, it is known that overweight and obese subjects have greater carotid diameters and 
measures of adiposity and higher SBP33. These associations were not explained by body surface, as they were 
independent of BSA in our study population.
Interestingly, similar associations were observed between renal length and volume and cIMT. As far as we 
are aware, this is the first description of an independent association between renal size and cIMT in healthy 
children. Indeed, previous works have focused on the association between several cardiovascular risk markers 
and impairment of renal function in adult patients. In hypertensive patients, cIMT correlated with increased 
concentration of cystatin C (n = 87)34 and, in another study, cIMT correlated with low eGRF (n = 1351)23. Others 
showed that atherosclerosis was a predictor of renal size and function in patients with atherosclerotic vascular 
disease (n = 1056)22. A lack of independent relationship between renal function and atherosclerosis in subjects 
with normal renal function was also described23,24. Similar results were observed in our cohort of healthy pre-
pubertal children. eGRF correlated with cIMT; however, the associations were not maintained in multivariate 
analysis including BSA and other confounding variables.
Our multivariate analyses showed that renal length together with perirenal fat were independent predictors 
of cIMT. Importantly, we have previously demonstrated a strong association between perirenal fat and cIMT, 
considering perirenal fat as a cardiovascular risk enhancer25. We suggested that the harmful impact of perirenal 
fat could be related to the local synthesis of adipocytokines that may impact on renal function. Renal size has 
also been previously proposed to play a role in estimating renal function in healthy children16. Hence, the present 
results pointed that perirenal fat and renal size could both modulate vascular function and thus be associated 
with cardiovascular risk. In these sense, there is a study in Ossabaw pigs with metabolic syndrome that shows that 
greater renal size and higher glomerular filtration rate associated with microvascular proliferation and proximal 
tubular vacuolization, as well as significant intrarrenal and perirenal adiposity35.
We have used renal length and volume to assess renal size. Both measures correlated with cIMT and SBP; 
however, in multivariate analysis, renal length, but no renal volume, was an independent predictor of cIMT and 
SBP. This discrepancy could be explained because of the better repeatability and accuracy of renal length meas-
urements compared to renal volume. Several authors suggest that renal length may be a better marker than renal 
volume because is easily reproduced and less technically demanding than renal volume, which requires several 
measurements in different planes and the application of a formula19,36.
We recognize a number of limitations in our study. In particular, the study has a cross sectional design, there-
fore it is not possible to explore a causative relationship between renal size and cardiovascular measures. However, 
this study seeks an interesting age group since atherosclerosis begins in childhood7. Moreover, children are not 
subjected to potential confounding conditions such as adult-onset metabolic complications. Our findings are 
All children 
(n = 515)
Lean (BMI-SDS <1) 
(n = 176)
Overweight  
(1< BMI-SDS <2)  
(n = 208)
Obese (BMI-SDS >2) 
(n = 131)
cIMT B p B p B p B p
Renal length 0.376 <0.0001 0.347 <0.0001 0.410 <0.0001 0.309 0.008
Renal volume 0.154 0.01 — — — — 0.269 0.03
SBP
Renal length 0.120 0.02 — — — — 0.277 0.008
Renal volume — — — — — — 0.235 0.04
Table 4. Multivariate linear regression analysis for cardiovascular risk factors (cIMT and SBP) and renal 
parameters adjusted for age, gender and BSA in the study subjects as a whole and in subgroups thereof 
according to BMI (lean, overweight and obese). cIMT: carotid intima-media thickness, SBP: systolic blood 
pressure, BSA: body surface area.
Beta Sig
cIMT
Renal length 0.310 <0.0001
Perirenal fat 0.233 <0.0001
R2 0.211
SBP
Renal length 0.116 0.03
BSA 0.463 <0.0001
R2 0.307
Table 5. Multivariate linear regression analyses for cardiovascular risk factors (cIMT and SBP) and renal 
parameters after further adjusting for perirenal fat and serum lipids in the studied subjects as a whole (n = 515). 
cIMT, carotid intima-media thickness; SBP, systolic blood pressure; Non predictive variables: age, gender, renal 
volume and lipids.
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additionally limited to a pediatric population of 515 healthy patients, indicating that future investigations are 
needed to confirm the link between renal length and cardiovascular risk. We have observed significant independ-
ent associations between renal size (length and volume) and SBP but not with DBP; however, SBP is considered to 
be a better parameter associated with CV risk37,38. Regarding the methodology, we have not measured intrarenal 
resistive index and even though both kidneys were measured, we only show data for the right one, as the meas-
urements of the left kidney were less reproducible in our study. Blood pressure was only measured on the right 
arm; however, all subjects had normal femoral pulse suggesting that none had aortic coarctation. Our study may 
have not excluded subjects with spurious hypertension, but we could not determine central SBP because it is an 
invasive measurement. cIMT was only measured on the right artery; however, we have shown consistent results 
regarding the association of cIMT with CV risk in a number of manuscripts39,40. No external validations for the 
ultrasound measurements were performed; however, cIMT and renal size have been shown to be easily and repro-
ducibly measured by ultrasound in numerous studies41,42.
In conclusion, our findings showed that renal size associated with cIMT and SBP, independently of other 
well-established risk factors. Renal length and perirenal fat were independent predictors of cIMT, while renal 
length and BSA were independent predictors of SBP. We propose that these renal parameters may play a role in 
the regulation of vascular function and may represent helpful parameters for the early prevention of cardiovas-
cular risk in children.
Methods
subjects and ethics. The study population consisted of 515 asymptomatic Caucasian children (283 boys 
and 232 girls; mean age 8.7 ± 0.1 years); 176 lean (BMI-SDS < 1); 208 overweight (1 ≤ BMI-SDS < 2) and 131 
obese (BMI-SDS ≥ 2). Subjects were enrolled in a study of obesity and cardiovascular risk factors in prepuber-
tal childhood and consecutively recruited among those seen in a primary care setting in Girona, a region in 
Northeastern Spain.
The inclusion criteria were 1) age between 6 and 10 years and 2) prepubertal status (Tanner stage I). Children 
with major congenital anomalies; abnormal liver, kidney or thyroid functions; evidence of chronic illness or 
prolonged use of medication; acute illness or use of medication in the month preceding potential enrolment were 
excluded from the study.
The study protocol was approved by the Institutional Review Board of Dr Josep Trueta Hospital. All research 
was performed in accordance with relevant guidelines and regulations. Informed written consent was obtained 
from all the parents.
Clinical assessments. Clinical examination was performed in the morning, in the fasting state, and it was 
followed by venous blood sampling. Weight and height were measured with a calibrated scale and a Harpenden 
stadiometer, respectively. Body mass index (BMI) was calculated as weight (in kg) divided by the square of height 
(in meters). Age-adjusted and sex-adjusted standard deviation scores (SDS) for BMI were calculated using 
regional normative data43. Body surface area (BSA) was calculated as the square root of height (in cm) * weight 
(in kg)/3600. Waist circumference was measured in the supine position at the umbilical level. Body composition 
was assessed by bioelectric impedance (Hydra Bioimpedance Analyzer 4200, Xitron Technologies, San Diego, 
CA). Fat mass (FM) percentage was calculated using the body weight and lean mass parameters [FM = (body 
weight − lean mass)/*100]. Systolic (SBP) and diastolic (DBP) blood pressure was measured on the right arm 
after a 10-min rest in the supine position by means of an electronic sphygmomanometer (Dinamap Pro 100, GE 
Healthcare, Chalfont St. Giles, United Kingdom). It was determined twice and an additional measurement was 
taken in case there was no agreement between the initial two measurements. Data are presented as the average of 
two concordant measurements. Information about birth parameters was abstracted from standardized medical 
records.
Laboratory assessments. All serum samples were obtained between 8:00 and 9:00 AM under fasting condi-
tions. Fasting serum glucose, immunoreactive insulin, serum alanine-aminotransferase (ALT), gamma-glutamyl 
transferase (GGT), creatinine, urea and lipids (total cholesterol, triglycerides and HDL-cholesterol) were rou-
tinely assessed in the clinical laboratory of the Hospital Dr. Josep Trueta (Architect system, Abbott Diagnostics 
Europe, Milan, Italy). Insulin resistance was calculated using the homeostasis model assessment of insulin resist-
ance (HOMA-IR = [fasting insulin in mUl−1] * [fasting glucose in mM]/22.5). Glomerular filtration rate (GFR) 
was estimated by the Haycock-Schwartz formula as follows: K × height (in cm)/creatinine (in umol/L), with a K 
value of 46 for all ages44.
Ultrasound assessments. Right kidney size (length, depth and width), perirenal fat and cIMT were meas-
ured by high-resolution ultrasonography (MyLabTM25, Esaote, Firenze, Italy). Averages of three measurements 
for each parameter were used in the study. Renal size was measured in both kidneys with the subjects placed in 
left lateral supine position. Given that the right kidney was more easily assessed, and so these measurements 
were more reproducible, we only show data of the right one. During ultrasound measurements, participants with 
abnormal morphometry in any of the kidneys, suggesting renal scar, reflux nephropathy, and those with asym-
metric kidneys, were further excluded from the study. Renal volume was calculated using the following formula 
[length * depth * width * 0.523]45. cIMT was measured on the right side at the level of the distal common carotid 
artery, one cm away from its bifurcation. Diastolic images were obtained using a linear 7.5–12 MHz transducer. 
Perirenal fat images were obtained using a convex 3–3.5 MHz transducer and fat thickness was measured as 
the distance from the inner side of the abdominal musculature to the surface of the right kidney. All measure-
ments were performed by the same observer who was unaware of the clinical and laboratory characteristics of the 
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subjects. Intra-subject coefficient of variation for ultrasound measurements was less that 6%. None of the children 
in our study showed ultrasonographic signs of atherosclerotic plaques.
statistics. Statistical analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, IL). Results are 
expressed as mean ± standard error of the mean (SEM). Logarithmic transformation was used to obtain normally 
distributed values for continuous variables. Differences across obesity groups were examined by ANOVA (contin-
uous data). The relation between variables was analyzed by Pearson bivariate correlations followed by multivariate 
linear regression analyses. The enter method was used for computing the independent variables. Significance level 
was set at p < 0.05.
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